Arbutus Biopharma Corp·4

Jul 10, 1:11 PM ET

Sofia Michael J. 4

4 · Arbutus Biopharma Corp · Filed Jul 10, 2018

Insider Transaction Report

Form 4
Period: 2018-07-06
Sofia Michael J.
Chief Scientific Officer
Transactions
  • Sale

    Common Shares

    2018-07-06$8.45/sh10,000$84,5001,523,403 total
  • Sale

    Common Shares

    2018-07-09$8.91/sh10,000$89,0601,513,403 total
Holdings
  • Common Shares

    (indirect: By Trust)
    171,412
Footnotes (2)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2017.
  • [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.50 to $9.35, inclusive. The reporting person undertakes to provide to Arbutus Biopharma Corp., any security holder of Arbutus Biopharma Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the rages set forth in this footnote.

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4